(Reuters) - U.S. stocks ended down on Monday, led by losses in biotech shares after disappointing news from several companies including Amgen.
The nation's largest airlines last week reported ridiculous - for them - first-quarter profits. And it had far less to do with the price of oil and jet fuel than you've probably read.
(Recasts with details, context; adds analyst comment). By Caroline Humer. April 27 (Reuters) - Mylan NV rejected Teva Pharmaceutical Industries Ltd's $40 billion takeover offer on Monday, saying in a scathing letter that it grossly undervalued the company ...
Shares of DuPont leapt on Monday after an influential shareholder advisory firm backed efforts by the activist investor Nelson Peltz to win seats on the industrial conglomerate's board.
... * Drop in healthcare stocks leads U.S. shares lower. * Reshuffled Greek negotiating team helps European shares. * Euro gains on Greece optimism.